Bronstein, M.D.

acromegaly treatment patient igf-i center choice month endocrinol consensus pegvisomant therapy europe italy somatostatin level outcome management giustina survey metab srl therapy analog macroadenoma respondent diagnosis chanson p somatostatin analogs treatment choice igf-i levels response melmed statement guideline surgery growth neurosurgery neurosurgeon chanson preference practice measurement result hormone vance ml physician assessment degli uberti e ghigo country gamma knife g specialist casanueva dopamine agonists e combination nadir casanueva ff acromegaly management j endocrinol criteria acromegaly patients 12 months consensus guidelines clin endocrinol srl treatment cavagnini f growth hormone lombardi g lambert ghigo e monotherapy radiotherapy endocrinology colao compromise minuto f vance strasburger cj participant los angeles mazziotti g